ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure

Bao, Nandi; Liu, Xiaoli; Zhong, Xiaoling; Jia, Shuangshuang; Hua, Ning; Zhang, Li*; Mo, Guoxin*安徽医科大学; 1
PEErJ2023-7-26DOI: 10.7717/peerj.15589
4被引6阅读
引用收藏
分享

摘要

Aim: To investigate the potential microbiome profile of a mouse model with heart failure (HF) during dapagliflozin treatment. Method: An HF model was constructed in 8-week-old male mice, and cardiac tissues were analyzed using histological staining. Hemodynamic indexes were measured, and fecal samples were collected for 16S rDNA sequencing. Chao1, Shannon, and Simpson were used for a-diversity analysis. b-Diversity analysis was conducted using principal coordinate analysis (PCoA) and non-metric multidimensional scaling (NMDS) based on the Bray-Curtis distance. Linear discriminant analysis coupled with effect size measurements (LEfSe) was used to identify signature gut microbiota, and phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was used to predict the function of altered gut microbiota.Result: Dapagliflozin treatment reduced inflammation, infarction area, and cardiac fibrosis in HF mice. It also increased endothelial-dependent dilation and inflammation in mice with HF. Dapagliflozin decreased the ratio of Firmicutes/ Bacteroidetes, which was increased in HF mice. There was no significant statistical difference in a-diversity among the control, HF, and HF+dapagliflozin groups. Desulfovibrio, AF12, and Paraprevotella were enriched in HF+dapagliflozin, while Rikenella and Mucispirillum were enriched in HF based on LEfSe. KEGG analysis revealed that altered gut microbiota was associated with fermentation, amino acid biosynthesis, nucleoside and nucleotide biosynthesis/degradation, fatty acid and lipid biosynthesis, carbohydrate biosynthesis/degradation, and cofactor/prosthetic group/ electron carrier/vitamin biosynthesis.Conclusion: Understanding the microbiome profile helps elucidate the mechanism of dapagliflozin for HF. The signature genera identified in this study could be used as a convenient method to distinguish between HF patients and healthy individuals.

学科与关键词

关键词
Heart failureGut microbiotaDapagliflozin16S rDNA sequencingSGLT-2 inhibitors
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PEErJ
发表日期
2023-07-26
卷期
第 11 卷
页码
e15589
DOI
10.7717/peerj.15589
语言
ENGLISH
成果收录
SCIE

作者

  • B

    Bao, Nandi (第一作者)

    chinese peoples liberat army gen hosp

  • L

    Liu, Xiaoli

    1 · chinese peoples liberat army pla gen hosp

查看全部 7 位作者收起作者
  • Z

    Zhong, Xiaoling

  • J

    Jia, Shuangshuang

    anhui med univ

  • H

    Hua, Ning

    chinese peoples liberat army gen hosp

  • Z

    Zhang, Li (通讯)

    chinese peoples liberat army gen hosp

  • M

    Mo, Guoxin (通讯)

    peoples liberat army gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417